9/26/2013 7:49:47 AM
One loss might be another one’s gain and that is applicable for Sun Pharma today. The stock is up on news that the company might reap windfall gains on one of its US drugs Doxil generic used for cancer. Reason being, Johnson and Johnson the innovator of Doxil is facing supply disruptions due to production issues at Ben Venue, its manufacturing partner.
Help employers find you! Check out all the jobs and post your resume.
comments powered by